Media Summary: In this segment the panelists discuss the important Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell Geoffrey R. Oxnard, MD, and Sandip Patel, MD, describe the value of large panel genetic profiling for metastatic non–small cell ...

Mutation Testing For Nsclc - Detailed Analysis & Overview

In this segment the panelists discuss the important Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell Geoffrey R. Oxnard, MD, and Sandip Patel, MD, describe the value of large panel genetic profiling for metastatic non–small cell ... In this segment, Benjamin Levy, MD, discusses current recommendations for genetic Biomarker Testing, Genomic Testing, Genetic Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of

Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic Jonathan W. Riess, MD, MS, determines the value of repeat In this video series that was recorded in July, September and November of 2025, leading oncologists present patients and ...

Photo Gallery

Mutation Testing for NSCLC
Mutation Testing in NSCLC
Widespread Mutation Testing for NSCLC
Mutation Testing for NSCLC in 2017
Non-Small Cell Lung Cancer: Subtypes, Molecular Testing and Mutations - 2024 Lung Cancer OncTalk
Mutation Testing for All Patients With NSCLC
Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?
Mutation Testing in Nonsquamous NSCLC
Mutation Testing to Guide ALK TKI Selection in NSCLC
Current Mutation Testing in Lung Cancer
Value of Repeat Mutation Testing for ALK+ NSCLC
How do doctors test for genetic mutations in lung cancer and why is it important?
View Detailed Profile
Mutation Testing for NSCLC

Mutation Testing for NSCLC

In this segment the panelists discuss the important

Mutation Testing in NSCLC

Mutation Testing in NSCLC

Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell

Widespread Mutation Testing for NSCLC

Widespread Mutation Testing for NSCLC

Geoffrey R. Oxnard, MD, and Sandip Patel, MD, describe the value of large panel genetic profiling for metastatic non–small cell ...

Mutation Testing for NSCLC in 2017

Mutation Testing for NSCLC in 2017

In this segment, Benjamin Levy, MD, discusses current recommendations for genetic

Non-Small Cell Lung Cancer: Subtypes, Molecular Testing and Mutations - 2024 Lung Cancer OncTalk

Non-Small Cell Lung Cancer: Subtypes, Molecular Testing and Mutations - 2024 Lung Cancer OncTalk

The 2024

Mutation Testing for All Patients With NSCLC

Mutation Testing for All Patients With NSCLC

The importance of

Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?

Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?

Biomarker Testing, Genomic Testing, Genetic

Mutation Testing in Nonsquamous NSCLC

Mutation Testing in Nonsquamous NSCLC

Benjamin P. Levy, MD, discusses the

Mutation Testing to Guide ALK TKI Selection in NSCLC

Mutation Testing to Guide ALK TKI Selection in NSCLC

Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of

Current Mutation Testing in Lung Cancer

Current Mutation Testing in Lung Cancer

Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic

Value of Repeat Mutation Testing for ALK+ NSCLC

Value of Repeat Mutation Testing for ALK+ NSCLC

Jonathan W. Riess, MD, MS, determines the value of repeat

How do doctors test for genetic mutations in lung cancer and why is it important?

How do doctors test for genetic mutations in lung cancer and why is it important?

Learn more about

How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26

How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26

In this video series that was recorded in July, September and November of 2025, leading oncologists present patients and ...